Hot Investor Mandate: Vision Care Company Seeks to Foster Early-Stage Innovation, Interested in All Technologies Associated with Ophthalmology

25 Feb

A health-focused vision care company committed to cultivating the eye health start-up ecosystem is looking to invest or partner with companies from seed to revenue stage, investing as early as POC through commercially available products. The firm is interested in technologies from all sectors that are related to eye health (including ocular surface disease, myopia, and glaucoma), or diagnostics or treatments for eye problems caused by other diseases, such as diabetes or neurological diseases. The firm will consider seed through late stage investing and partnerships with companies in the US and abroad.

The firm will consider all companies associated with vision, ophthalmology, and vision care. This includes all sectors, and could range from new therapeutics to treat glaucoma to digital health technologies to improve vision insurance. The firm will also consider technologies treating vision problems that are secondary effects of other indications, such as diabetes.

The firm can lead or co-invest. In addition, the firm will use their network for help with product rollout, if relevant.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

<span>%d</span> bloggers like this: